PacBio to Report Fourth Quarter 2024 Financial Results on February 13, 2025

(NASDAQ:PACB), MENLO PARK, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2024 financial results on Thursday, February 13, 2025, at 4:30 pm Eastern Time. The call will be webcast and may be accessed at PacBio's website at https://investor.pacificbiosciences.com/. […]

Viasat Sets February 6, 2025 for Third Quarter Fiscal Year 2025 Financial Results Conference Call and Webcast

(NasdaqGM:VSAT), CARLSBAD., Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Viasat, Inc. (NASDAQ: VSAT), a global leader in satellite communications, today announced it will release its third quarter fiscal year 2025 financial results on Thursday, February 6, 2025 after the market closes, via a letter to shareholders posted to the Investor Relations section of its website.

Methode Electronics Appoints Karen Keegans as Chief Human Resources Officer

(NYSE:MEI), CHICAGO, Jan. 30, 2025 (GLOBE NEWSWIRE) — Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting, and power distribution applications, announced today that Karen Keegans has been appointed as Chief Human Resources Officer (CHRO) effective February 3, 2025. Ms. Keegans succeeds Andrea Barry, who has served as

MU Announcement: Kessler Topaz Meltzer & Check, LLP Encourages Micron Technology, Inc. (MU) Investors to Contact the Firm About Securities Fraud Class Action Lawsuit

RADNOR, PA / ACCESS Newswire / January 30, 2025 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Micron Technology, Inc. ("Micron") (NASDAQ:MU) on behalf of those who purchased or otherwise acquired Micron common stock between September 28, 2023, and

Archrock Increases Quarterly Cash Dividend

(NYSE:AROC), HOUSTON, Jan. 30, 2025 (GLOBE NEWSWIRE) — Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today announced that its Board of Directors has declared an increased quarterly dividend of $0.19 per share of common stock, or $0.76 per share on an annualized basis. The fourth quarter 2024 dividend will be paid on February 19,

Orchid Island Capital Announces Fourth Quarter 2024 Results

(NYSE:ORC), VERO BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) — Orchid Island Capital, Inc. (NYSE:ORC) (“Orchid” or the “Company”), a real estate investment trust (“REIT”), today announced results of operations for the three and twelve month periods ended December 31, 2024. Fourth Quarter 2024 Results Net income of $5.6 million, or $0.07 per common share,

Flotek Industries Announces Timing of Fourth Quarter and Full-Year 2024 Earnings Release; Expects Strongest Quarterly Results of 2024

Flotek Industries, Inc. (“Flotek” or the “Company”) (NYSE: FTK) today announced the Company's schedule for releasing its fourth quarter and full-year financial and operating results for the periods ended December 31, 2024. https://mma.prnewswire.com/media/493816/Flotek_Logo.jpg Chief Executive Officer Dr. Ryan Ezell commented, “We look forward to reporting our fourth quarter results, which we currently expect will be

Aristocrat Gaming™ Hosts World Casino Premiere of All-New House of the Dragon™ Slot Game with Series Star Steve Toussaint at Wynn Las Vegas

Based on the hit HBO® Original Series, House of the Dragon, new slot game brings to life recognizable characters, icons and dragons Actor Steve Toussaint joined casino players and executives from Wynn Las Vegas and Aristocrat Gaming to celebrate the world premiere of the all-new House of the Dragon slot game. https://mma.prnewswire.com/media/2610009/DSC_3365CU.jpg Click Here for

FIRST FINANCIAL BANK ANNOUNCES PROMOTION OF CHRIS SCHJETNAN TO EXECUTIVE VICE PRESIDENT, DIRECTOR OF COMMUNITY LENDING AND OUTREACH

The Board of Directors of First Financial Bank has announced the promotion of Chris Schjetnan to Executive Vice President, Director of Community Lending and Outreach. In this role, Chris will lead the Bank's affordable banking initiatives which focus on traditionally underserved communities. “Chris's unique background makes him an ideal candidate to fill this important new

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board

(NASDAQ:ACRS), WAYNE, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced the formation of a new Scientific Advisory Board (SAB), which initially includes experts in the field of pulmonology. These include Marianne Mann, M.D., and Zuzana Diamant,

Scroll to Top